Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosis

IntroductionThe study aimed to investigate the diagnostic and prognostic value of serum S100A8/9 levels with sHLHa, a high-mortality multiorgan inflammatory syndrome with no reliable clinical biomarkers, where calreticulin’s role is unclear.MethodsThis was a study of 67 newly diagnosed sHLHa patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziwei Fang, Xin Gao, Limin Duan, Jujuan Wang, Tian Tian, Ji Xu, Yongqian Shu, Guangli Yin, Hongxia Qiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2025.1607352/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849318586395394048
author Ziwei Fang
Xin Gao
Limin Duan
Jujuan Wang
Tian Tian
Ji Xu
Yongqian Shu
Guangli Yin
Hongxia Qiu
author_facet Ziwei Fang
Xin Gao
Limin Duan
Jujuan Wang
Tian Tian
Ji Xu
Yongqian Shu
Guangli Yin
Hongxia Qiu
author_sort Ziwei Fang
collection DOAJ
description IntroductionThe study aimed to investigate the diagnostic and prognostic value of serum S100A8/9 levels with sHLHa, a high-mortality multiorgan inflammatory syndrome with no reliable clinical biomarkers, where calreticulin’s role is unclear.MethodsThis was a study of 67 newly diagnosed sHLHa patients. 48 patients met criteria and were analyzed. ELISA detected S100A8/9 levels in patients and controls. The optimal classification threshold for S100A8/9 was determined to be 2.44 µg/mL by restricted cubic spline (RCS) curve analysis. Patients were categorized. Correlations, diagnostic efficacy, survival differences, and prognosis impacts were analyzed.ResultsSerum S100A8/9 levels in sHLHa patients were greater than in healthy controls. Various analyses showed its diagnostic and prognostic value. ANC<1.0 × 109/L and high S100A8/9 expression group were independent risk factors for poor prognosis in patients with sHLHa. It’s correlated with liver function indicators and HScore.DiscussionThis study evaluates S100A8/9 in sHLHa diagnosis and prognosis. S100A8/9 levels are useful for differentiating patients, providing etiologic and survival info. They show a nonlinear positive correlation with survival and a threshold effect. Serum S100A8/9 levels offer potential biomarkers, and further studies are needed.
format Article
id doaj-art-9123c17b9b41438bbced5ebd5a8afbb8
institution Kabale University
issn 2296-889X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj-art-9123c17b9b41438bbced5ebd5a8afbb82025-08-20T03:50:48ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2025-07-011210.3389/fmolb.2025.16073521607352Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosisZiwei Fang0Xin Gao1Limin Duan2Jujuan Wang3Tian Tian4Ji Xu5Yongqian Shu6Guangli Yin7Hongxia Qiu8Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, ChinaIntroductionThe study aimed to investigate the diagnostic and prognostic value of serum S100A8/9 levels with sHLHa, a high-mortality multiorgan inflammatory syndrome with no reliable clinical biomarkers, where calreticulin’s role is unclear.MethodsThis was a study of 67 newly diagnosed sHLHa patients. 48 patients met criteria and were analyzed. ELISA detected S100A8/9 levels in patients and controls. The optimal classification threshold for S100A8/9 was determined to be 2.44 µg/mL by restricted cubic spline (RCS) curve analysis. Patients were categorized. Correlations, diagnostic efficacy, survival differences, and prognosis impacts were analyzed.ResultsSerum S100A8/9 levels in sHLHa patients were greater than in healthy controls. Various analyses showed its diagnostic and prognostic value. ANC<1.0 × 109/L and high S100A8/9 expression group were independent risk factors for poor prognosis in patients with sHLHa. It’s correlated with liver function indicators and HScore.DiscussionThis study evaluates S100A8/9 in sHLHa diagnosis and prognosis. S100A8/9 levels are useful for differentiating patients, providing etiologic and survival info. They show a nonlinear positive correlation with survival and a threshold effect. Serum S100A8/9 levels offer potential biomarkers, and further studies are needed.https://www.frontiersin.org/articles/10.3389/fmolb.2025.1607352/fullphagocytic lymphohistiocytosisS100A8/9RCSdiagnosisprognosis
spellingShingle Ziwei Fang
Xin Gao
Limin Duan
Jujuan Wang
Tian Tian
Ji Xu
Yongqian Shu
Guangli Yin
Hongxia Qiu
Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosis
Frontiers in Molecular Biosciences
phagocytic lymphohistiocytosis
S100A8/9
RCS
diagnosis
prognosis
title Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosis
title_full Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosis
title_fullStr Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosis
title_full_unstemmed Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosis
title_short Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosis
title_sort expression and clinical significance of s100a8 9 in adults with secondary phagocytic lymphohistiocytosis
topic phagocytic lymphohistiocytosis
S100A8/9
RCS
diagnosis
prognosis
url https://www.frontiersin.org/articles/10.3389/fmolb.2025.1607352/full
work_keys_str_mv AT ziweifang expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis
AT xingao expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis
AT liminduan expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis
AT jujuanwang expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis
AT tiantian expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis
AT jixu expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis
AT yongqianshu expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis
AT guangliyin expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis
AT hongxiaqiu expressionandclinicalsignificanceofs100a89inadultswithsecondaryphagocyticlymphohistiocytosis